Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam

International Journal of Pharmaceutics
Abdulaziz M Al-MahallawiMona H Aburahma

Abstract

Bilosomes represent an evolving vesicular carrier that have been explored for oral vaccines delivery based on its ability to resist enzymes and bile salts in the gastrointestinal tract (GIT). Bilosomes vesicles are formed of bilayer membrane of non-ionic surfactant molecules encompassing bile salts. Although, bilosomes have not been proposed for transdermal drug delivery, this carrier seems to have promising potential in this regard. Accordingly, the aim of this investigation was to assess the capability and safety of utilizing bilosomes for transdermal delivery of tenoxicam (TX) as a model drug. A 3(1)2(2) full factorial design was adopted to study the effects of different formulation parameters on bilosomes properties and select the optimal formulation using Design-Expert(®) software. The selected formulation displayed nano-sized spherical vesicles (242.5 ± 6.43nm) with reasonable entrapment efficiency percent (68.33 ± 2.33%). Confocal laser scanning microscopy confirmed the capability of the flourolabeled bilosomes to penetrate deep within the skin. Both, ex vivo permeation and in vivo skin deposition studies confirmed the superiority of bilosomes over drug solution in delivering TX transdermally. In addition, in vivo histop...Continue Reading

References

Jan 29, 1990·Biochimica Et Biophysica Acta·W Abraham, D T Downing
Dec 13, 1996·Biochimica Et Biophysica Acta·M KirjavainenJ Mönkkönen
Jul 8, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·L CoderchJ L Parra
Jul 29, 2000·Drug Development and Industrial Pharmacy·O N el-Gazayerly
May 20, 2003·International Journal of Pharmaceutics·D D VermaA Fahr
Apr 29, 2004·International Journal of Pharmaceutics·G M M El MaghrabyB W Barry
Jan 18, 2006·Methods : a Companion to Methods in Enzymology·Jamie F S MannValerie A Ferro
Nov 2, 2006·Expert Opinion on Drug Delivery·Heather A E Benson
Apr 6, 2007·AAPS PharmSciTech·Rania M HathoutAhmed S Guinedi
Jun 26, 2008·International Journal of Pharmaceutics·Mahmoud MokhtarNagia A Megrab
Jul 9, 2008·Journal of Microencapsulation·Maha NasrA A Elshamy
Oct 27, 2009·AAPS PharmSciTech·Pratap S JadonNarayanan Ganesh
Jul 14, 2010·Journal of Biomedical Science·Lakshmi N RamanaUma M Krishnan
Jan 20, 2011·Journal of Pharmaceutical Sciences·Hamdy AbdelkaderRaid G Alany
Apr 30, 2011·International Journal of Pharmaceutics·Nina Dragicevic-CuricAlfred Fahr
Sep 15, 2011·Pharmaceutical Development and Technology·Shahira F El-Menshawe, Amal K Hussein
Jun 6, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Surajit DasReginald B H Tan
Aug 14, 2012·Journal of Liposome Research·Hamed A SalamaGehanne A S Awad
Dec 18, 2012·AAPS PharmSciTech·Sureewan DuangjitTanasait Ngawhirunpat
Aug 13, 2013·BioMed Research International·Saeed Ghanbarzadeh, Sanam Arami
Sep 17, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Sanyog JainAshish Kumar Agrawal
Nov 26, 2013·International Journal of Pharmaceutics·Li-Na ShenNian-Ping Feng
Nov 28, 2013·International Journal of Pharmaceutics·Mengmeng NiuWei Wu
May 17, 2014·International Journal of Nanomedicine·Wei Meng LimYew Beng Kang
Jun 28, 2014·International Journal of Nanomedicine·Ibrahim ElsayedAhmed Hassen Elshafeey
Apr 1, 2005·Drug Discovery Today. Technologies·P Loan Honeywell-Nguyen, Joke A Bouwstra
Aug 13, 2014·International Journal of Nanomedicine·Thirapit SubongkotTanasait Ngawhirunpat
Sep 24, 2014·International Journal of Nanomedicine·Syed MahmoodUttam Kumar Mandal

❮ Previous
Next ❯

Citations

Apr 23, 2016·Expert Opinion on Drug Delivery·Célia FaustinoCatarina Pinto Reis
Jan 28, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Abdul AhadAbdullah M Al-Mohizea
Dec 19, 2019·Journal of Drug Targeting·Morteza RabieiSteven J P McInnes
Nov 9, 2017·Drug Development and Industrial Pharmacy·Azza Abdelmageed MatloubHanaa Hamdy Ahmed
Nov 24, 2018·Frontiers in Pharmacology·Nebojša PavlovićMomir Mikov
Oct 9, 2019·Technology and Health Care : Official Journal of the European Society for Engineering and Medicine·S KecmanS Golocorbin-Kon
Mar 16, 2019·The Journal of Pharmacology and Experimental Therapeutics·Karthik Yadav JangaSoumyajit Majumdar
Oct 31, 2020·International Journal of Pharmaceutics·Lamiaa R AbdelalimYosra S R Elnaggar
Feb 14, 2021·International Journal of Molecular Sciences·Maria Chiara di GregorioLuciano Galantini
Mar 22, 2021·International Journal of Pharmaceutics·Abdulaziz M Al-MahallawiSally A El-Zahaby
Aug 16, 2021·International Journal of Pharmaceutics·Marianne J NaguibWessam H Abd-Elsalam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.